Symbols

HRTX

Heron Therapeutics·NASDAQ

--(--)

6.71 / 10

Netural

Fund flow analysis scores 7.92/10, indicating robust fund flow characteristics. Bullish trends in overall, block, Medium, and Extra-large contrast with bearish signals in Small and Large, suggesting positive liquidity momentum. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(100.0%) from 1 analytical reports, supported by 5.49 historical weighted rating.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

100%

Buy

Hold

Sell

Strong Sell

Date2026-01-09

InstitutionHC Wainwright & Co.

Times predicted2

Historical Win Rate50.0%

Is money flowing into or out of HRTX?

HRTX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.71/10 (Netural).